HALIFAX, Jan. 24, 2014 /CNW/ - MedMira Inc., (MedMira) (TSXV: MIR), a developer of rapid testing technologies and solutions, reported that
the Company's Board of Directors was elected at its 2014 Annual General
Meeting of Shareholders held earlier today in Halifax, N.S. Mr. Hermes
Chan, Dr. Shou-Ching Tang, Mr. Romano Robusto, Mr. Markus Meile and Dr.
Michael Sidler were re-elected as directors of MedMira.
Shareholders also approved the appointment of Deloitte LLP as the
MedMira is a leading developer and manufacturer of rapid testing
technology and solutions. The Company's tests provide hospitals, labs,
clinics and individuals with reliable, rapid diagnosis for diseases
such as HIV and hepatitis C in just three minutes. The Company's tests
are sold under the Reveal®, Multiplo™ and Miriad brands in global
markets. MedMira's patented rapid flow-through HIV test is the only one
in the world to achieve regulatory approvals in Canada, the United
States, China and the European Union. MedMira's corporate offices and
manufacturing facilities are located in Halifax, Nova Scotia, Canada.
For more information visit MedMira's website at www.medmira.com.
This news release contains forward-looking statements, which involve
risk and uncertainties and reflect the Company's current expectation
regarding future events including statements regarding possible
approval and launch of new products, future growth, and new business
opportunities. Actual events could materially differ from those
projected herein and depend on a number of factors including, but not
limited to, changing market conditions, successful and timely
completion of clinical studies, uncertainties related to the regulatory
approval process, establishment of corporate alliances and other risks
detailed from time to time in the company quarterly filings.
Neither TSX Venture Exchange nor its Regulation Services Provider (as
that term is defined in the policies of the TSX Venture Exchange)
accepts responsibility for the adequacy or accuracy of this release.
SOURCE: MEDMIRA INC.
For further information:
Andrea Young, Corporate Communications